ISPC
Income statement / Annual
Last year (2025), iSpecimen Inc's total revenue was $1.93 M,
a decrease of 79.24% from the previous year.
In 2025, iSpecimen Inc's net income was -$10.49 M.
See iSpecimen Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.93 M |
$9.29 M |
$9.93 M |
$10.40 M |
$11.14 M |
$8.18 M |
$4.30 M |
$4.39 M |
| Cost of Revenue |
$1.90 M
|
$5.30 M
|
$4.82 M
|
$4.76 M
|
$5.25 M
|
$3.59 M
|
$2.13 M
|
$2.36 M
|
| Gross Profit |
$24.11 K
|
$3.99 M
|
$5.11 M
|
$5.65 M
|
$5.89 M
|
$4.60 M
|
$2.17 M
|
$2.03 M
|
| Gross Profit Ratio |
0.01
|
0.43
|
0.51
|
0.54
|
0.53
|
0.56
|
0.5
|
0.46
|
| Research and Development Expenses |
$0.00
|
$3.53 M
|
$3.57 M
|
$2.66 M
|
$1.84 M
|
$1.47 M
|
$993.33 K
|
$1.21 M
|
| General & Administrative Expenses |
$3.47 M
|
$7.70 M
|
$7.72 M
|
$8.93 M
|
$6.98 M
|
$3.26 M
|
$2.85 M
|
$2.19 M
|
| Selling & Marketing Expenses |
$2.30 M
|
$4.95 M
|
$3.96 M
|
$3.45 M
|
$2.42 M
|
$1.78 M
|
$1.41 M
|
$1.31 M
|
| Selling, General & Administrative Expenses |
$5.77 M
|
$12.65 M
|
$11.68 M
|
$12.37 M
|
$9.40 M
|
$5.04 M
|
$4.26 M
|
$3.51 M
|
| Other Expenses |
$3.23 M
|
$537.89 K
|
$1.03 M
|
$801.13 K
|
$573.91 K
|
$497.18 K
|
$792.78 K
|
$41.73 K
|
| Operating Expenses |
$9.00 M
|
$16.72 M
|
$16.28 M
|
$15.83 M
|
$11.81 M
|
$7.01 M
|
$6.05 M
|
$5.39 M
|
| Cost And Expenses |
$10.91 M
|
$22.02 M
|
$21.10 M
|
$20.59 M
|
$17.06 M
|
$10.59 M
|
$8.18 M
|
$7.75 M
|
| Interest Income |
$3.75 K
|
$44.13 K
|
$339.75 K
|
$169.35 K
|
$11.40 K
|
$437.00
|
$630.00
|
$1.50 K
|
| Interest Expense |
$1.95 K
|
$220.07 K
|
$230.79 K
|
$238.96 K
|
$2.10 M
|
$2.10 M
|
$1.72 M
|
$1.21 M
|
| Depreciation & Amortization |
$1.73 M
|
-$56.47 K
|
$2.07 M
|
$1.21 M
|
$1.00 M
|
$819.69 K
|
$634.97 K
|
$469.17 K
|
| EBITDA |
-$8.75 M |
-$12.73 M |
-$8.80 M |
-$8.80 M |
-$5.86 M |
-$1.74 M |
-$2.52 M |
-$3.79 M |
| EBITDA Ratio |
-4.53
|
-1.37
|
-0.89
|
-0.85
|
-0.53
|
-0.21
|
-0.59
|
-0.86
|
| Operating Income Ratio |
-4.65
|
-1.37
|
-1.13
|
-0.98
|
-0.53
|
-0.29
|
-0.9
|
-0.76
|
| Total Other Income/Expenses Net |
-$1.51 M
|
$230.24 K
|
$69.86 K
|
-$59.84 K
|
-$3.04 M
|
-$2.25 M
|
-$1.00 M
|
-$2.12 M
|
| Income Before Tax |
-$10.49 M
|
-$12.50 M
|
-$11.10 M
|
-$10.25 M
|
-$8.96 M
|
-$4.65 M
|
-$4.88 M
|
-$5.47 M
|
| Income Before Tax Ratio |
-5.44
|
-1.35
|
-1.12
|
-0.98
|
-0.8
|
-0.57
|
-1.14
|
-1.25
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$157.00 K
|
-$127.00 K
|
| Net Income |
-$10.49 M
|
-$12.50 M
|
-$11.10 M
|
-$10.25 M
|
-$8.96 M
|
-$4.65 M
|
-$4.73 M
|
-$5.35 M
|
| Net Income Ratio |
-5.44
|
-1.35
|
-1.12
|
-0.98
|
-0.8
|
-0.57
|
-1.1
|
-1.22
|
| EPS |
-91.2 |
-703.2 |
-49.2 |
-818.8 |
-980.4 |
-5775.2 |
-4039.6 |
-4564.4 |
| EPS Diluted |
-91.2 |
-703.2 |
-982 |
-817.6 |
-980.4 |
-5775.2 |
-4039.6 |
-4564.4 |
| Weighted Average Shares Out |
$115.06 K
|
$17.77 K
|
$11.30 K
|
$11.04 K
|
$10.22 K
|
$1.17 K
|
$1.17 K
|
$1.17 K
|
| Weighted Average Shares Out Diluted |
$115.06 K
|
$17.77 K
|
$11.30 K
|
$11.06 K
|
$10.22 K
|
$1.17 K
|
$1.17 K
|
$1.17 K
|
| Link |
|
|
|
|
|
|
|
|
